Skip to main content
. 2014 Aug 13;6:759–769. doi: 10.2147/IJWH.S53489

Table 1.

Drugs approved for the prevention and treatment of osteoporosis

Pharmacologic category United States European Union
Bisphosphonate Alendronate
Risedronate
Ibandronate
Zoledronic acid
Alendronate
Risedronate
Ibandronate
Zoledronic acid
Etidronate
Clodronateb
RANK ligand inhibitor Denosumab Denosumab
SERM Raloxifene Raloxifene
Bazedoxifenea
Parathyroid hormone and derivatives Teriparatide Teriparatide
Parathyroid hormone
Other Estrogen/HRT
Calcitonin
Vitamin D
HRT
Strontium ranelate
Calcitonin
Vitamin D and derivatives

Notes:

a

Available only in Greece, Spain, and Germany

b

approved for osteoporosis in only some countries Data from Kanis et al,17 health.ny.gov,23 and nof.gov.24

Abbreviations: HRT, hormone replacement therapy; RANK, receptor activator of nuclear factor-kappa B; SERM, selective estrogen receptor modulator.